Royal Holloway and CABI both bring a combination of individual scientific skills, expertise and resources to the project. When brought together, these offer the opportunity to build a highly focused natural products drug discovery operation that will address the urgent need for bringing new antibiotic compounds to market.

In the latest issue of the journal Emerging Infectious Diseases, Swedish researchers report that birds captured in the hyperboreal tundra, in connection with the tundra expedition “Beringia 2005,” were carriers of antibiotics-resistant bacteria.

Over the course of the 20th Century, doctors waged war against infectious bacterial illness with the best new weapon they had: antibiotics.

It has no current market, not even a prescription price. Its makers stopped commercial production years ago, because demand was so low. But an antibiotic long abandoned as a weak, low-dose treatment for tuberculosis (TB) may have found renewed purpose, this time as a potent, high-dose fighter against the most common and actively contagious form of the lung disease.

Hunter researchers have shown that a commonly available antibiotic can improve the quality of life of patients with difficult asthma, and may also generate significant health care savings.

Scientists from The University of Manchester have pioneered new ways of tweaking the molecular structure of antibiotics – an innovation that could be crucial in the fight against powerful super bugs.

Discovery by Hebrew University of Jerusalem researchers of a new communication factor that enables bacteria to “talk to each other” and causes their death could have significant consequences leading to development of a new class of antibiotic medications.

Antibiotics are not justified to reduce the risk of complications after upper respiratory tract infection, sore throat, or ear infection, finds a study published on bmj.com today.

Researchers have discovered a strain of bacteria resistant to all approved drugs used to fight ear infections in children, according to an article to be published tomorrow in the Journal of the American Medical Association (JAMA). A pair of pediatricians discovered the strain because it is their standard practice to perform an uncommon procedure called tympanocentesis (ear tap) on children when several antibiotics fail to clear up their ear infections.

Although doctors routinely use IV antibiotics to cure patients with severe urinary tract infections (UTI), a new review from suggests that oral antibiotics work just as well — from treating acute symptoms to preventing long-term complications of UTI.

The reasons why physicians prescribe antibiotics inappropriately are not fully understood. Inappropriate antibiotic use is an important problem worldwide.

In the battle against bacteria, researchers have scored a direct hit. They have made a discovery that could shorten the road to new and more potent antibiotics.